Olema Oncology announced the appointment of Sean P. Bohen, M.D., Ph.D., as Chief Executive Officer. Dr. Bohen was most recently Executive Vice President of Global Medicines Development and Chief Medical Officer at AstraZeneca. Dr. Bohen succeeds Cyrus Harmon, Ph.D., who had served as President and Chief Executive Officer of Olema since the company was founded.